Postpartum and Post Abortion Diagnoses DRG 769 Reimbursement

DRG 769 encompasses postpartum and post abortion inpatient admissions that include operating room procedures, addressing surgical management of obstetric complications and related operative care. This Diagnosis-Related Group matters for inpatient reimbursement because operative obstetric encounters typically generate higher resource use and influence Medicare payment determination and hospital case-mix classification.

DRG 769 Overview

DRG 769 covers inpatient hospital admissions for postpartum and post abortion diagnoses that include operating room procedures, such as surgical management of obstetric complications or procedures related to abortion care. This Diagnosis-Related Group groups cases where an operating room procedure significantly increases resource use compared with nonoperative postpartum or post abortion care. Understanding this DRG is important for Medicare inpatient reimbursement because operative obstetric care typically raises payment relative to nonoperative cases and affects case mix and hospital billing. Accurate coding of the procedures and principal diagnoses drives payment assignment under Centers for Medicare & Medicaid Services inpatient prospective payment policies.

Acute surgical intervention and hemostasis trials focusing on intraoperative techniques and adjunctive measures to manage postpartum hemorrhage, uterine atony, and retained products of conception. These studies enroll women undergoing cesarean delivery or postpartum operative procedures and compare modalities such as advanced uterine-sparing surgical techniques, use of topical hemostatic agents, or hemostatic device protocols during the index O.R. encounter. Findings are relevant to surgeons and hospitals because they directly affect intraoperative blood loss, transfusion requirements, length of stay, and immediate resource utilization under this DRG.
Comparative effectiveness studies evaluating alternative operative approaches and timing for management of postpartum complications, including comparisons between repeat cesarean, laparotomy versus minimally invasive re-exploration, and staged procedures for retained placenta or infection. These trials typically recruit postpartum patients who require operative management within the index hospitalization and assess outcomes such as complication rates, need for reoperation, readmission, and cost-effectiveness across strategies. Payers and providers benefit from this evidence to optimize care pathways that balance clinical outcomes with downstream costs and DRG reimbursement implications.
Post-discharge outcomes and quality-of-life studies assessing longer-term maternal recovery, infection sequelae, pelvic floor function, and mental health after operative postpartum or post-abortion procedures. These observational cohorts or pragmatic trials follow patients after hospital discharge to measure readmissions, outpatient resource utilization, wound complications, breastfeeding success, and functional recovery over weeks to months. This research informs discharge planning, bundled payment models, and targeted interventions to reduce preventable readmissions and improve value for patients categorized under this DRG.

Acute surgical intervention and hemostasis trials focusing on intraoperative techniques and adjunctive measures to manage postpartum hemorrhage, uterine atony, and retained products of conception. These studies enroll women undergoing cesarean delivery or postpartum operative procedures and compare modalities such as advanced uterine-sparing surgical techniques, use of topical hemostatic agents, or hemostatic device protocols during the index O.R. encounter. Findings are relevant to surgeons and hospitals because they directly affect intraoperative blood loss, transfusion requirements, length of stay, and immediate resource utilization under this DRG.
Comparative effectiveness studies evaluating alternative operative approaches and timing for management of postpartum complications, including comparisons between repeat cesarean, laparotomy versus minimally invasive re-exploration, and staged procedures for retained placenta or infection. These trials typically recruit postpartum patients who require operative management within the index hospitalization and assess outcomes such as complication rates, need for reoperation, readmission, and cost-effectiveness across strategies. Payers and providers benefit from this evidence to optimize care pathways that balance clinical outcomes with downstream costs and DRG reimbursement implications.
Post-discharge outcomes and quality-of-life studies assessing longer-term maternal recovery, infection sequelae, pelvic floor function, and mental health after operative postpartum or post-abortion procedures. These observational cohorts or pragmatic trials follow patients after hospital discharge to measure readmissions, outpatient resource utilization, wound complications, breastfeeding success, and functional recovery over weeks to months. This research informs discharge planning, bundled payment models, and targeted interventions to reduce preventable readmissions and improve value for patients categorized under this DRG.

OpenPayer

Summary & Overview

Postpartum and Post Abortion Diagnoses with O.R. Procedures: Inpatient Reimbursement Overview

DRG 769 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes